Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Belatacept 250mg powder for solution for infusion vials |
| BNF code | 0802020Y0AAAAAA |
| Virtual Therapeutic Moiety | Belatacept |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | vial |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Belatacept |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 250.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | solutioninfusion.intravenous |
| Dose Form | |
| Formulation | Powder for solution for infusion |
| Drug Route | |
| Route | Intravenous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Nulojix 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) | |
| Virtual Medicinal Product Packs | |
| Belatacept 250mg powder for solution for infusion vials 1 vial | |
| Belatacept 250mg powder for solution for infusion vials 2 vial | |
dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.